Results 171 to 180 of about 12,091 (231)

Unmasking Additional Mutations: A Single Institution Study in Myeloproliferative Neoplasms. [PDF]

Cancers (Basel)
Tizro P, Vail E, Sapkota M, Gayhart MG, Eno CC.   +4 more
europepmc   +1 more source

CALR NP_004334.1:p.K385fs*47 [PDF]

, 2020
openaire   +1 more source

Clinical features and outcomes of MPN with concurrent MPL and JAK2/CALR Mutations. [PDF]

Blood Neoplasia
Chen YH, Gajjar S, You V, Komrokji R, Nardi V, Tsai H, Xie Z, Kuykendall A, Hobbs GS.   +8 more
europepmc   +1 more source

Neutrophil-to-lymphocyte ratio as a gene-specific biomarker of JAK2-driven inflammation across CHIP and myeloproliferative neoplasms. [PDF]

Front Oncol
Barbui T.
europepmc   +1 more source

Isolated del(5q) with myeloproliferative driver mutations: A systematic review of published cases and clinical implications. [PDF]

Ther Adv Hematol
Abdulgayoom M, Al-Mashdali AF, Alshurafa A, Afana MS, Babiker AM, Bakheet M, Mohamed SF, Yassin MA.   +7 more
europepmc   +1 more source

Lactylation-mediated remodelling of the breast cancer microenvironment: single-cell multidimensional analysis and prognostic model construction. [PDF]

Front Immunol
Chen J, Hao Y, Feng Y, Dai Y, Shi H, Zhu L.   +5 more
europepmc   +1 more source

Adolescent and Young Adult versus Older Adult Philadelphia-Negative Myeloproliferative Neoplasms: A Single-Center Experience from the MENA Region. [PDF]

J Blood Med
Mohamed SF, Alshurafa A, Soliman DS, Al-Mashdali AF, Abdulgayoom M, Babiker AM, Osman M, Fadul A, Abdalla E, Alsayed AA, Aweer NA, Abdel-Rahman ME, Ismail OM, Yousaf A, Yassin M.   +14 more
europepmc   +1 more source

Molecular Response, Event-Free Survival, and Treatment-Free Remission in Myeloproliferative Neoplasms: Update and Review with Insights from MPN Asia 2026. [PDF]

Curr Hematol Malig Rep
Abu-Zeinah G, Hobbs GS, Rampal RK, Lee SE, Gill H, Komrokji R, Tashi T, Bose P, Mascarenhas J, Yacoub A, Oh ST, Shimoda K, Reeves BN, Duan M, Yu LH, Qin A, Prchal JT, Kaushansky K, Mesa RA.   +18 more
europepmc   +1 more source

Optimized Test Utilization Significantly Increased the Positive Detection Rate for Myeloproliferative Neoplasms. [PDF]

Cancers (Basel)
Nfonsam LE, Qi MZ, Butcher DT, Campbell CJV, Cocca A, Dalmia S, Davies GA, Hohenadel BA, McCready E.   +8 more
europepmc   +1 more source

Damage-Associated Molecular Patterns in Mesothelioma: Drivers of Inflammation and Therapeutic Targets. [PDF]

Int J Mol Sci
Molinario A, Caprioglio F, Rilievo AA, Bianchi ME, Mezzapelle R.   +4 more
europepmc   +1 more source